Home
MOLN
MOLN News

Latest Molecular Partners AG (MOLN) News on August 24, 2025

Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025

GlobeNewswire

2 months ago

Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

GlobeNewswire

2 months ago

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

MT Newswires

2 months ago

Molecular Partners to Reduce up to 24% of Workforce

Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway

GlobeNewswire

2 months ago

Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway

Molecular Partners to Present at Upcoming Investor Conferences

GlobeNewswire

3 months ago

Molecular Partners to Present at Upcoming Investor Conferences

Molecular Partners Reports Financial Results and Highlights from Q1 2025

GlobeNewswire

3 months ago

Molecular Partners Reports Financial Results and Highlights from Q1 2025

Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025

GlobeNewswire

4 months ago

Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025

Molecular Partners Announces all Board Proposals Approved at Annual General Meeting

GlobeNewswire

4 months ago

Molecular Partners Announces all Board Proposals Approved at Annual General Meeting

Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher

Zacks

5 months ago

Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher

Molecular Partners to hold three poster presentations at AACR 2025

GlobeNewswire

5 months ago

Molecular Partners to hold three poster presentations at AACR 2025

Molecular Partners Publishes Invitation to Annual General Meeting 2025

GlobeNewswire

5 months ago

Molecular Partners Publishes Invitation to Annual General Meeting 2025

Molecular Partners AG (MLLCF) (FY 2024) Earnings Call Highlights: Strategic Shifts and ...

GuruFocus.com

6 months ago

Molecular Partners AG (MLLCF) (FY 2024) Earnings Call Highlights: Strategic Shifts and ...

Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024

GlobeNewswire

6 months ago

Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024

Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call

GlobeNewswire

6 months ago

Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference

Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer

GlobeNewswire

7 months ago

Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer

Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January

GlobeNewswire

8 months ago

Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January

Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet

Zacks

8 months ago

Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024

GlobeNewswire

9 months ago

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024

Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024

GlobeNewswire

10 months ago

Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024

Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition

GlobeNewswire

10 months ago

Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition

Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going

GlobeNewswire

10 months ago

Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going

Molecular Partners Announces Pricing of $20 Million Underwritten Offering

GlobeNewswire

10 months ago

Molecular Partners Announces Pricing of $20 Million Underwritten Offering

Molecular Partners Expands Radio-DARPin Collaboration

TipRanks

10 months ago

Molecular Partners Expands Radio-DARPin Collaboration

MT Newswires

10 months ago

Molecular Partners, Orano Med Report Positive Preclinical Data on MP0712

Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024

GlobeNewswire

10 months ago

Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024

Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics

GlobeNewswire

10 months ago

Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics

Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting

GlobeNewswire

a year ago

Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting

Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024

GlobeNewswire

a year ago

Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024

MT Newswires

a year ago

Molecular Partners H1 Net Loss Narrows, Revenue Rises

Molecular Partners Reports H1 2024 Corporate Highlights and Financials

GlobeNewswire

a year ago

Molecular Partners Reports H1 2024 Corporate Highlights and Financials

Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit

GlobeNewswire

a year ago

Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit

Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024

GlobeNewswire

a year ago

Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024

Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024

GlobeNewswire

a year ago

Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024

Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024

GlobeNewswire

a year ago

Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024

Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program

GlobeNewswire

a year ago

Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program

Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action

GlobeNewswire

a year ago

Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action

Life Science Cares Launches in Switzerland

GlobeNewswire

a year ago

Life Science Cares Launches in Switzerland

Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting

GlobeNewswire

a year ago

Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting

Molecular Partners Publishes Invitation to Annual General Meeting 2024

GlobeNewswire

a year ago

Molecular Partners Publishes Invitation to Annual General Meeting 2024

Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023

GlobeNewswire

a year ago

Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023

The past three years for Molecular Partners (VTX:MOLN) investors has not been profitable

Simply Wall St.

a year ago

The past three years for Molecular Partners (VTX:MOLN) investors has not been profitable

Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations

GlobeNewswire

a year ago

Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations

Fisker Leadership to Attend National Automobile Dealers Association Show as Company Makes Strategic Shift to Dealer Partnerships

Business Wire

2 years ago

Fisker Leadership to Attend National Automobile Dealers Association Show as Company Makes Strategic Shift to Dealer Partnerships

Porch Group Receives $25M with Signing of Strategic Agreement with Aon

Business Wire

2 years ago

Porch Group Receives $25M with Signing of Strategic Agreement with Aon

WebBank, a Steel Partners Company, Honored as One of the Best Places to Work in 2024, a Glassdoor Employees’ Choice Award Winner

Business Wire

2 years ago

WebBank, a Steel Partners Company, Honored as One of the Best Places to Work in 2024, a Glassdoor Employees’ Choice Award Winner

Industry-Recognized Technology Leader Joins DLH as Strategic Advisor

GlobeNewswire

2 years ago

Industry-Recognized Technology Leader Joins DLH as Strategic Advisor

LuxUrban Hotels Inc. (NASDAQ:LUXH) Has Found A Path To Profitability

Simply Wall St.

2 years ago

LuxUrban Hotels Inc. (NASDAQ:LUXH) Has Found A Path To Profitability

Office Properties Income Trust's Dividend Analysis

GuruFocus.com

2 years ago

Office Properties Income Trust's Dividend Analysis

Strength Seen in Lantronix, Inc. (LTRX): Can Its 11.6% Jump Turn into More Strength?

Zacks

2 years ago

Strength Seen in Lantronix, Inc. (LTRX): Can Its 11.6% Jump Turn into More Strength?

3 Once-in-a-Lifetime Stocks on the Verge of an Unprecedented Surge

InvestorPlace

2 years ago

3 Once-in-a-Lifetime Stocks on the Verge of an Unprecedented Surge

Bit Digital, Inc. Announces Upsized Customer Contract for Bit Digital AI

PR Newswire

2 years ago

Bit Digital, Inc. Announces Upsized Customer Contract for Bit Digital AI

Why Beyond Meat Stock Gained 22% in December

Motley Fool

2 years ago

Why Beyond Meat Stock Gained 22% in December

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results

PR Newswire

2 years ago

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results

Here's Why You Should Retain Accuray (ARAY) Stock for Now

Zacks

2 years ago

Here's Why You Should Retain Accuray (ARAY) Stock for Now

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

2 years ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

GlobeNewswire

2 years ago

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery

Bloomberg

2 years ago

WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery

CTO Realty Growth Announces 2023 Transaction and Leasing Activity and Provides Share Repurchase Update

GlobeNewswire

2 years ago

CTO Realty Growth Announces 2023 Transaction and Leasing Activity and Provides Share Repurchase Update

HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

Newsfile

2 years ago

HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

How Amprius (AMPX) Stock Stands Out in a Strong Industry

Zacks

2 years ago

How Amprius (AMPX) Stock Stands Out in a Strong Industry

Rayonier (RYAM) Declares Amendment to Term Loan Credit Agreement

Zacks

2 years ago

Rayonier (RYAM) Declares Amendment to Term Loan Credit Agreement

15 Best Software Stocks to Buy Now According to Coatue Management

Insider Monkey

2 years ago

15 Best Software Stocks to Buy Now According to Coatue Management

Superior Group of Companies, Inc.'s (NASDAQ:SGC) largest shareholders are retail investors with 35% ownership, institutions own 34%

Simply Wall St.

2 years ago

Superior Group of Companies, Inc.'s (NASDAQ:SGC) largest shareholders are retail investors with 35% ownership, institutions own 34%

Are Robust Financials Driving The Recent Rally In Myers Industries, Inc.'s (NYSE:MYE) Stock?

Simply Wall St.

2 years ago

Are Robust Financials Driving The Recent Rally In Myers Industries, Inc.'s (NYSE:MYE) Stock?

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

Simply Wall St.

2 years ago

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

Retail investors account for 43% of Molecular Partners AG's (VTX:MOLN) ownership, while hedge funds account for 33%

Simply Wall St.

2 years ago

Retail investors account for 43% of Molecular Partners AG's (VTX:MOLN) ownership, while hedge funds account for 33%

Third Coast Bancshares, Inc. Declares Quarterly Cash Dividend on its 6.75% Series A Convertible Non-Cumulative Preferred Stock

PR Newswire

2 years ago

Third Coast Bancshares, Inc. Declares Quarterly Cash Dividend on its 6.75% Series A Convertible Non-Cumulative Preferred Stock

Should You Invest in Laboratory Corporation of America Holdings (LH)?

Insider Monkey

2 years ago

Should You Invest in Laboratory Corporation of America Holdings (LH)?

Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences

GlobeNewswire

2 years ago

Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences

$Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting$

GlobeNewswire

2 years ago

Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting

Favourable Signals For Codorus Valley Bancorp: Numerous Insiders Acquired Stock

Simply Wall St.

2 years ago

Favourable Signals For Codorus Valley Bancorp: Numerous Insiders Acquired Stock

IperionX 2023 Sustainability Report

Business Wire

2 years ago

IperionX 2023 Sustainability Report

Tutor Perini Announces Executive Leadership Changes

Business Wire

2 years ago

Tutor Perini Announces Executive Leadership Changes

Molecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summit Europe (PEGS)

GlobeNewswire

2 years ago

Molecular Partners to Present on DARPin Oncology Innovations at Protein & Antibody Engineering Summit Europe (PEGS)

WhiteHorse Finance, Inc. (NASDAQ:WHF) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

WhiteHorse Finance, Inc. (NASDAQ:WHF) Q3 2023 Earnings Call Transcript

Standard Lithium Reports Fiscal First Quarter 2024 Results

GlobeNewswire

2 years ago

Standard Lithium Reports Fiscal First Quarter 2024 Results

We're Keeping An Eye On Molecular Partners' (VTX:MOLN) Cash Burn Rate

Simply Wall St.

2 years ago

We're Keeping An Eye On Molecular Partners' (VTX:MOLN) Cash Burn Rate

There's A Lot To Like About PCB Bancorp's (NASDAQ:PCB) Upcoming US$0.18 Dividend

Simply Wall St.

2 years ago

There's A Lot To Like About PCB Bancorp's (NASDAQ:PCB) Upcoming US$0.18 Dividend

NACCO Industries, Inc. (NYSE:NC) is definitely on the radar of institutional investors who own 34% of the company

Simply Wall St.

2 years ago

NACCO Industries, Inc. (NYSE:NC) is definitely on the radar of institutional investors who own 34% of the company

Share on Social Networks: